#ASCO26: Yes, Revolution Medicines' pancreatic cancer data are that good

CHICAGO — When oncologist Brian Wolpin saw the positive results from Revolution Medicines' pivotal pancreatic cancer study for the first time, he was rendered speechless, he told Endpoints News. “Honestly, I just sort of stared at ...